Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 2009-12-30 (16 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: L'ISLE-EN-DODON (31230), Haute-Garonne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELAS PHARMACIE L'ISLOISE : revenue, balance sheet and financial ratios
SELAS PHARMACIE L'ISLOISE is a French company
founded 16 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in L'ISLE-EN-DODON (31230),
this company of category PME
shows in 2025 a net income positive of 13 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELAS PHARMACIE L'ISLOISE (SIREN 519487946)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
13 430 €
259 117 €
358 445 €
372 927 €
328 141 €
382 091 €
366 184 €
343 043 €
300 009 €
316 658 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, SELAS PHARMACIE L'ISLOISE generates positive net income of 13 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 317 k€ -> 13 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
13 430 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 29%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 68%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
29.043%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
185.993
114.632
81.208
50.846
28.412
13.253
33.587
30.395
25.895
29.043
Financial autonomy
30.867
39.094
49.25
59.588
69.37
79.391
67.055
68.446
70.92
68.027
Repayment capacity
None
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
29.042025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Good+5 pts over 3 years
In 2025, the debt ratio of SELAS PHARMACIE L'ISLOISE (29.04) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
68.03%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Good-6 pts over 3 years
In 2025, the financial autonomy of SELAS PHARMACIE L'ISLOISE (68.0%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 794.76. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
112.852
90.279
139.873
153.743
146.625
153.116
120.844
121.718
125.042
794.763
Interest coverage
None
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
794.762025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Excellent+52 pts over 3 years
In 2025, the liquidity ratio of SELAS PHARMACIE L'ISLOISE (794.76) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of SELAS PHARMACIE L'ISLOISE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SELAS PHARMACIE L'ISLOISE is estimated at
213 337 €
(range 144 771€ - 334 755€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
144k€213k€334k€
213 337 €Range: 144 771€ - 334 755€
NAF 5 année 2025
Valuation method used
Net Income Multiple
13 430 €
×
15.9x
=213 337 €
Range: 144 772€ - 334 755€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELAS PHARMACIE L'ISLOISE with other companies in the same sector:
Frequently asked questions about SELAS PHARMACIE L'ISLOISE
What is the revenue of SELAS PHARMACIE L'ISLOISE ?
The revenue of SELAS PHARMACIE L'ISLOISE is not publicly disclosed (confidential accounts filed with INPI).
Is SELAS PHARMACIE L'ISLOISE profitable?
Yes, SELAS PHARMACIE L'ISLOISE generated a net profit of 13 k€ in 2025.
Where is the headquarters of SELAS PHARMACIE L'ISLOISE ?
The headquarters of SELAS PHARMACIE L'ISLOISE is located in L'ISLE-EN-DODON (31230), in the department Haute-Garonne.
Where to find the tax return of SELAS PHARMACIE L'ISLOISE ?
The tax return of SELAS PHARMACIE L'ISLOISE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELAS PHARMACIE L'ISLOISE operate?
SELAS PHARMACIE L'ISLOISE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart